A BIM (BCL2L11) deletion polymorphism that results in the generation of alternatively spliced isoforms of BIM that lack the crucial BH3 domain and confers an EGFR TKI resistant phenotype in NSCLC cell lines (104) can be epigenetically restored restored by HDAC inhibition. The gene discussed is BCL2L11; the disease is non-small cell lung carcinoma.